COX inhibitor Amfenac sodium monohydrate, Purity ≥98%

Cat. No.: X23-10-ZQ642

COX inhibitor Amfenac sodium monohydrate, Purity ≥98%

Synonym: 61618-27-7; Sodium 2-(2-amino-3-benzoylphenyl)acetate hydrate; Amfenac sodium hydrate; Amfenac sodium monohydrate; Amfenac sodium H2O; Amfenac sodium salt monohydrate; COX inhibitor

  • MDL: MFCD00941383
  • CAS Number: 61618-27-7
  • Compound CID: 23663941
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Amfenac sodium monohydrate, soluble in DMSO, water and ethanol, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Weight
295.27
Molecular Formula
C15H12NO3.H2O.Na
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 50 mg/mL (169.33 mM); Water: 50 mg/mL (169.33 mM); Ethanol: 3 mg/mL (10.16 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Amfenac sodium monohydrate is investigated for its anti-inflammatory and analgesic properties, particularly in the treatment of ocular inflammation.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0